Sign inGet started

Lavelle Erin M.

Insider CIK 1813250 · NLTX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
NLTX Neoleukin Therapeutics, In A Award deriv2021-05-112021-05-1325,000— $025,000SEC↗
NLTX Neoleukin Therapeutics, In A Award deriv2020-06-012020-06-0250,000— $050,000SEC↗